BR0208364A - Novos peptìdeos ligantes das integrinas de leucócitos e uso dos mesmos - Google Patents

Novos peptìdeos ligantes das integrinas de leucócitos e uso dos mesmos

Info

Publication number
BR0208364A
BR0208364A BR0208364-7A BR0208364A BR0208364A BR 0208364 A BR0208364 A BR 0208364A BR 0208364 A BR0208364 A BR 0208364A BR 0208364 A BR0208364 A BR 0208364A
Authority
BR
Brazil
Prior art keywords
peptides
new
binding peptides
pharmaceutical compositions
inflammatory diseases
Prior art date
Application number
BR0208364-7A
Other languages
English (en)
Inventor
Erkki Koivunen
Carl G Gahmberg
Original Assignee
Ctt Cancer Targeting Tech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctt Cancer Targeting Tech Oy filed Critical Ctt Cancer Targeting Tech Oy
Publication of BR0208364A publication Critical patent/BR0208364A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"NOVOS PEPTìDEOS LIGANTES DAS INTEGRINAS DE LEUCóCITOS E USO DOS MESMOS". A presente invenção refere-se a novos peptídeos que são úteis como antagonistas das integrinas <225>2, para composições farmacêuticas compreendendo estes peptídeos, ao uso dos novos peptídeos para fabricação de composições farmacêuticas para tratamento de doenças inflamatórias e de leucemias humanas e para inibir a adesão das células dos leucócitos e a migração em geral, a um método para tratamento terapêutico e profilático das doenças inflamatórias e de leucemias humanas e ao uso dos novos peptídeos como antagonistas das integrinas <225>2 para isolamento bioquímico e para procedimentos de purificação in vitro.
BR0208364-7A 2001-03-12 2002-03-11 Novos peptìdeos ligantes das integrinas de leucócitos e uso dos mesmos BR0208364A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010491A FI114710B (fi) 2001-03-12 2001-03-12 Leukosyytti-integriinien uusia peptidiligandeja
PCT/FI2002/000188 WO2002072618A1 (en) 2001-03-12 2002-03-11 Novel peptide ligands of leukocyte integrins

Publications (1)

Publication Number Publication Date
BR0208364A true BR0208364A (pt) 2004-03-09

Family

ID=8560720

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208364-7A BR0208364A (pt) 2001-03-12 2002-03-11 Novos peptìdeos ligantes das integrinas de leucócitos e uso dos mesmos

Country Status (20)

Country Link
US (1) US7205383B2 (pt)
EP (1) EP1373303A1 (pt)
JP (1) JP2004536041A (pt)
KR (1) KR20030093238A (pt)
CN (1) CN1860129A (pt)
BR (1) BR0208364A (pt)
CA (1) CA2441210A1 (pt)
CZ (1) CZ20032632A3 (pt)
EE (1) EE200300443A (pt)
FI (1) FI114710B (pt)
HR (1) HRP20030708A2 (pt)
HU (1) HUP0402246A2 (pt)
IL (1) IL157831A0 (pt)
NO (1) NO20034002L (pt)
NZ (1) NZ528044A (pt)
PL (1) PL365108A1 (pt)
RU (1) RU2003130082A (pt)
SK (1) SK12762003A3 (pt)
WO (1) WO2002072618A1 (pt)
YU (1) YU70903A (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI115035B (fi) * 2003-05-02 2005-02-28 Ctt Cancer Targeting Tech Oy In vivo -kuvantaminen käyttäen peptidijohdannaisia
CN103458911B (zh) * 2011-02-11 2016-02-24 密歇根大学董事会 肽组合物和用于治疗患者的方法
AU2012291972B2 (en) * 2011-08-04 2017-03-09 Pharis Biotec Gmbh Process for preparing human relaxin-2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877275A (en) * 1988-06-28 1999-03-02 The General Hospital Corporation Controlling cellular immune/inflammatory responses with β2 integrins
GB9213077D0 (en) * 1992-06-19 1992-08-05 Erba Carlo Spa Polymerbound taxol derivatives
US5840485A (en) * 1993-05-27 1998-11-24 Selectide Corporation Topologically segregated, encoded solid phase libraries
US5821329A (en) * 1996-06-06 1998-10-13 Tanabe Seiyaku Co., Ltd. Cyclic peptide inhibitors of β1 and β2 integrin-mediated adhesion

Also Published As

Publication number Publication date
JP2004536041A (ja) 2004-12-02
FI20010491A0 (fi) 2001-03-12
HRP20030708A2 (en) 2005-04-30
HUP0402246A2 (hu) 2005-01-28
EP1373303A1 (en) 2004-01-02
SK12762003A3 (sk) 2004-02-03
KR20030093238A (ko) 2003-12-06
IL157831A0 (en) 2004-03-28
FI114710B (fi) 2004-12-15
FI20010491A (fi) 2002-09-13
PL365108A1 (en) 2004-12-27
US7205383B2 (en) 2007-04-17
YU70903A (sh) 2006-05-25
RU2003130082A (ru) 2005-02-20
NO20034002L (no) 2003-11-12
US20040259798A1 (en) 2004-12-23
NO20034002D0 (no) 2003-09-10
CA2441210A1 (en) 2002-09-19
WO2002072618A1 (en) 2002-09-19
CZ20032632A3 (cs) 2003-12-17
CN1860129A (zh) 2006-11-08
EE200300443A (et) 2003-12-15
NZ528044A (en) 2005-01-28

Similar Documents

Publication Publication Date Title
BRPI0415613A (pt) novos compostos de diazaspiroalcanos e seu uso no tratamento de doenças mediadas por ccr8
BR0206985A (pt) Anticorpos modificados e métodos de uso
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
ATE510558T1 (de) Verwendung von biologisch aktivem hiv-1 tat, fragmenten oder derivaten davon, zur bestimmung und/oder aktivierung von antigen-präsentierenden zellen, und/oder zur abgabe von cargo-molekülen für impfung und/oder für behandlung von anderen erkrankungen
BR0007663A (pt) Derivados de acila para uso no tratamento de doenças relacionadas com o vla-4
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
ATE389724T1 (de) Menschliche dnase i hyperaktive varianten
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell&#39;epidermide
BR9801652A (pt) Resorcinil-triazinas
BR0110091A (pt) Composições e processos para terapia e diagnóstico de câncer de mama
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
BR9702074A (pt) Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações
NO20043792L (no) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
ATE198467T1 (de) Diaromatische propynyl- oder dienylverbindungen
DE60229235D1 (de) D kupfersulfaten und sucralphat
TR200100637T2 (tr) Yeni doğal ürün türevleri
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
BR0208364A (pt) Novos peptìdeos ligantes das integrinas de leucócitos e uso dos mesmos
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
DE60135454D1 (de) Pharmazeutische gel-zusammensetzung
ATE278011T1 (de) Human dnase ii

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.